Saudi Arabia – A Vital Middle East Hub for Clinical Trials

What makes Saudi Arabia the go-to location for clinical research and how trusted, local expertise can help overcome key barriers.

21

May

  • 3PM London / 10AM New York
  • Free
  • Why attend?
  • Speakers
  • Contact Us

Why attend?

Global clinical trials are moving through one of their most unsettled phases to date. Escalating costs, evolving regulatory frameworks, geopolitical uncertainty, and increasingly intricate study designs are redefining how research is conducted worldwide. Sponsors are under growing strain, from data-intensive protocols and limited patient availability to supply chain disruption and policy shifts that put R&D investment at risk.

Against this backdrop, Saudi Arabia is emerging with resilience as the Middle East’s largest pharmaceutical market, while rapidly strengthening its position within the global clinical research ecosystem.

Join the team at Oximio, a global clinical supply chain solutions provider, for this upcoming webinar as they examine the key economic forces, market developments, and strategic opportunities driving Saudi Arabia’s rise as a key hub for clinical trials in the Middle East.
A must-attend webinar for those planning or running clinical trials in the Middle East, Oximio delivers practical insights and expert guidance to help navigate logistical challenges within the region.

You’ll hear from Zayheda Khan, Oximio’s Chief Commercial Officer and Günes Yildirim, Regional Director for MENA (Middle East and North Africa).

  • Saudi Arabia’s position in the global/Middle East clinical trial stage, including key therapies & the use of virtual components in clinical trials.
  • What makes Saudi Arabia reliable hub for clinical trials.
  • Challenges and economic drivers
  • Hear from members of the Oximio team, who will share advice and experiences.

Speakers

Select a speaker to learn more

Back
Zayheda Khan
Chief Commercial Officer, Oximio

Zayheda Khan was appointed Chief Commercial Officer in December 2022 and UK Managing Director in October 2024.

She has more than 20 years experience in a variety of roles within the clinical trial sectors including preclinical, clinical, proposal and budgeting, procurement and programme management.

Zayheda oversees the Marketing, Sales/KAM, Commercial Operations, Procurement and Project Management functions with the aim of assessing customer needs and providing cost-effective tailor-made solutions.

She is also responsible for the commercial data analysis for accurate forecasts and opportunity pipeline management and her organisation is driven to develop customer partnerships and drive forward the success of the commercial projects in an ever-changing clinical trial landscape.

Zayheda has a Bachelor’s Degree from the University of Central Lancashire and Master and PhD Degrees in Pharmacology from The University of Bradford.

Next speaker
Back
Günes Yildirim
Regional Director for MENA (Middle East and North Africa), Oximio.


Günes is a highly experienced professional with 22+ years of operational experience in site management, clinical operations, and logistics operations in the clinical trials sector.

Prior to her current role as Regional Director for MENA, she was appointed to the role of Managing Director for Türkiye operations in Jan 2023, having acted as Türkiye’s Warehouse Manager, responsible for managing all GDP & GMP operations. She was at the forefront of the implementation of several processes, system changes, and cross-functional collaboration.

She holds a B.Sc. in Biology and an MBA, is based in Izmir- Türkiye, and is leading the Oximio MENA Teams.

Next speaker

Enquiry